sawoven9
Preclinical evaluation of a novel triple-acting PIM/PI3K/Venetoclax, IBL-302, in cancers of the breast
https://www.selleckchem.com/products/PD-0332991.html
No history to display
When sawoven9 listens to shows or tracks they will be shown here